Market Overview

Medtronic Narrows FY13 EPS Outlook

Share:
Related MDT
What Specific Role Will Apple Play In IBM's Watson Health Cloud Alliance?
The Big Health Data Orgy Happening In The Cloud
IBM Employs Watson Capabilities Into Healthcare Analytics (Seeking Alpha)

In a presentation to investors, Medtronic, Inc. (NYSE: MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013.

The Company tightened its fiscal 2013 diluted EPS guidance range to $3.66 to $3.70 from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%.

Posted-In: News Guidance

 

Related Articles (MDT)

Around the Web, We're Loving...

Get Benzinga's Newsletters